teva

  1. Teva Pharma gets FDA approval

    Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will be a real threat to Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...
    • anonymous
    • Thread
    • drug price epipen generic drugs healthcare mylan pharma regeneron teva teva pharmaceuticals
    • Replies: 3
    • Forum: Teva Respiratory

  2. pillow

    Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will end the monopoly of Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...
    • anonymous
    • Thread
    • drug price epipen fda generic drugs mylan regeneron teva teva neuro psych teva neuroscience teva pharmaceuticals
    • Replies: 0
    • Forum: Teva Neuroscience

  3. Allergan to pay $700 million to Teva

    Allergan agrees to pay $700 million to Teva in this quarter. Teva discloses this in an SEC filing.
    • anonymous
    • Thread
    • agreement allergan arbitration settlement teva teva pharmaceuticals
    • Replies: 1
    • Forum: Allergan

  4. Chopping block

    So the CNE group heard by the end of the month layoffs would happen. Does anyone have intell on what nurse territories will be eliminated or how long the program will even exist? I have also heard nurses will not be supporting frem. So what is it will will be doing?
    • anonymous
    • Thread
    • cne neuroscience teva
    • Replies: 0
    • Forum: Teva Neuroscience

  5. Will Pfizer again attempt to acquire Allergan?

    When providing the outlook for 2018, Saunders said that Allergan faces LOE losses in 2018. But still it has got good long-term prospects. Saunders says that current stock price doesn't reflect Allergan's true value. Wall Street gives thumbs up to his speech.
    • anonymous
    • Thread
    • acquisition allergan guidance job cuts outlook pfizer teva
    • Replies: 4
    • Forum: Allergan

  6. Lilly in the migraine drug race

    http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab. Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than...
    • anonymous
    • Thread
    • amgen eli lilly fda lawsuit migraine novartis patent pfizer teva
    • Replies: 8
    • Forum: Eli Lilly

  7. How to get in on Teva epipen sales?

    Hey folks, been looking at Teva jobs and interested in getting in on the Teva Epipen side when it comes out. Are the sales reps for it going to be in respiratory, or should I be looking for another department? I've typed in epipen and epinephrine and nothing is coming up for jobs.
    • anonymous
    • Thread
    • epinephrine epipen teva
    • Replies: 3
    • Forum: Teva Respiratory

  8. Teva epinephrine?

    When is this Teva epipen thing coming out? I asked the doctor but he hasn't heard anything about it from his Teva rep yet, so I guess the reps aren't shoving it in his face like Mylan. I saw that its been failing all sorts of things with the FDA but may finally be ok? Any chance there will...
    • allergiessuck
    • Thread
    • allergy epinephrine epipen mylan teva
    • Replies: 1
    • Forum: Teva Respiratory

  9. Allergan planning sale of its Teva stock

    Allergan swings to quarterly loss on charges related to Teva holding and also its Restasis drug.

  10. Brent Saunders says Allergan stock is undervalued

    Allergan swings to quarterly loss on charges related to Restasis and Teva holding. Given the Federal Court's decision, plans to mitigate the financial impact of generic competition http://alph.st/b68181eb
    • anonymous
    • Thread
    • allergan earnings pfizer restasis shire teva
    • Replies: 1
    • Forum: Allergan
Top Bottom
Back